XML 23 R13.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Earnings per Share | 6 Months Ended
--- | ---
Jul. 30, 2022
Earnings Per Share [Abstract] |
Earnings per Share | 5. Earnings per Share The following is a reconciliation between the amounts used in the calculation of basic and diluted earnings per share:
|  | 13 Weeks Ended |  |  | 26 Weeks Ended |
|  | July 30, |  |  | July 31, |  |  | July 30, |  |  | July 31, |
(In thousands) |  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Weighted average common shares outstanding: |  |  |  |  |  |  |  |  |  |  |  |
Basic number of common shares outstanding |  |  | 180,189 |  |  |  | 167,491 |  |  |  | 174,544 |  |  |  | 168,036 |
Dilutive effect of convertible notes |  |  | — |  |  |  | 36,367 |  |  |  | — |  |  |  | 35,083 |
Dilutive effect of stock options and non-vested restricted stock |  |  | — |  |  |  | 5,075 |  |  |  | — |  |  |  | 5,281 |
Diluted number of common shares outstanding |  |  | 180,189 |  |  |  | 208,933 |  |  |  | 174,544 |  |  |  | 208,400 |
Anti-Dilutive Shares (1) (2) |  |  | 29,221 |  |  |  | 130 |  |  |  | 38,763 |  |  |  | 130 |
(1) For the 13 and 26 weeks ended July 30, 2022, there were 3.9 million and 1.9 million potentially dilutive equity awards, respectively, that were excluded from the diluted earnings per share calculation because the Company incurred a net loss for this period and their inclusion would be anti-dilutive. (2) For the 13 and 26 weeks ended July 30, 2022, there were 25.3 million and 36.8 million potentially dilutive shares from the Company’s 2025 Notes, respectively, that were excluded from the diluted earnings per share calculation because the Company incurred a net loss for this period and their inclusion would be anti-dilutive. Dilutive and anti-dilutive shares relate to share-based compensation. Refer to Notes 8 and 9 to the Consolidated Financial Statements for additional information regarding the 2025 Notes and share-based compensation, respectively. On June 3, 2022, the Company entered into an accelerated share repurchase agreement (the “ASR Agreement”) with JPMorgan Chase Bank (“JPM”). Pursuant to the terms of the ASR Agreement, on June 3, 2022, the Company paid $200.0 million in cash and received an initial delivery of 13.4 million shares of its common stock on June 3, 2022. At final settlement, on July 28, 2022, an additional 3.7 million shares were received. The cumulative repurchase under the ASR Agreement was 17.0 million shares repurchased at an average price per share of $11.75. The aforementioned shares have been recorded as treasury stock.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration